Загрузка...

Racial Differences in Clinical Outcomes for Metastatic Renal Cell Carcinoma Patients Treated With Immune-Checkpoint Blockade

BACKGROUND: Immune-checkpoint-inhibitors (ICIs) have become the cornerstone of metastatic renal-cell-carcinoma (mRCC) therapy. However, data are limited regarding clinical outcomes by race. In this study, we compared the real-world outcomes between African American (AA) and Caucasian mRCC patients t...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Front Oncol
Главные авторы: Olsen, T. Anders, Martini, Dylan J., Goyal, Subir, Liu, Yuan, Evans, Sean T., Magod, Benjamin, Brown, Jacqueline T., Yantorni, Lauren, Russler, Greta Anne, Caulfield, Sarah, Goldman, Jamie M., Harris, Wayne B., Kucuk, Omer, Carthon, Bradley C., Master, Viraj A., Nazha, Bassel, Bilen, Mehmet Asim
Формат: Artigo
Язык:Inglês
Опубликовано: Frontiers Media S.A. 2021
Предметы:
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC8242950/
https://ncbi.nlm.nih.gov/pubmed/34222024
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2021.701345
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!